Literature DB >> 11478837

Liver transplantation for type Ib glycogenosis with reversal of cyclic neutropenia.

A López-Sanromán, P Martín-Vaquero, E Molina-Pérez, R Bárcena, E Vicente, L F Pallardo-Sánchez.   

Abstract

We describe a case of glycogen storage disease type Ib in 32-year old male patient with poor metabolic control in spite of medical and nutritional management and the use of recombinant granulocyte stimulating factor. Because of this, liver transplantation was considered as a definitive treatment. We comment on the metabolic results of liver transplantation performed, with reversal of hypoglycemia, hyperuricemia, hypertriglyceridemia and cyclic neutropenia, all of which persist 4 years post-transplant. In view of this case, we believe that liver transplantation is a feasible option to consider in patients with type Ib glycogenosis as a definitive therapeutic procedure. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11478837     DOI: 10.1054/clnu.2001.0432

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  9 in total

Review 1.  Liver transplantation for non-hepatotoxic inborn errors of metabolism.

Authors:  William R Treem
Journal:  Curr Gastroenterol Rep       Date:  2006-06

Review 2.  Gene therapy for type I glycogen storage diseases.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Curr Gene Ther       Date:  2007-04       Impact factor: 4.391

3.  Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice.

Authors:  W H Yiu; C-J Pan; M Allamarvdasht; S Y Kim; J Y Chou
Journal:  Gene Ther       Date:  2006-09-28       Impact factor: 5.250

Review 4.  Inborn errors of metabolism underlying primary immunodeficiencies.

Authors:  Nima Parvaneh; Pierre Quartier; Parastoo Rostami; Jean-Laurent Casanova; Pascale de Lonlay
Journal:  J Clin Immunol       Date:  2014-08-01       Impact factor: 8.317

5.  Improved neutrophil function in a glycogen storage disease type 1b patient after liver transplantation.

Authors:  Masanori Adachi; Masato Shinkai; Youkatsu Ohhama; Katsuhiko Tachibana; Tadatoshi Kuratsuji; Hiroh Saji; Etsuko Maruya
Journal:  Eur J Pediatr       Date:  2004-02-11       Impact factor: 3.183

Review 6.  The SLC37 family of phosphate-linked sugar phosphate antiporters.

Authors:  Janice Y Chou; Hyun Sik Jun; Brian C Mansfield
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

Review 7.  Neutropenia in type Ib glycogen storage disease.

Authors:  Janice Y Chou; Hyun S Jun; Brian C Mansfield
Journal:  Curr Opin Hematol       Date:  2010-01       Impact factor: 3.284

Review 8.  Liver transplantation in glycogen storage disease type I.

Authors:  Susanna J B Boers; Gepke Visser; Peter G P A Smit; Sabine A Fuchs
Journal:  Orphanet J Rare Dis       Date:  2014-04-09       Impact factor: 4.123

9.  Esophageal Stricture Secondary to Candidiasis in a Child with Glycogen Storage Disease 1b.

Authors:  Kyung Jae Lee; Shin Jie Choi; Woo Sun Kim; Sung-Sup Park; Jin Soo Moon; Jae Sung Ko
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2016-03-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.